Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)
South Korea · Delayed Price · Currency is KRW 28,950
-50 (-0.17%)
Apr 24, 2026, 3:30 PM KST
Daihan Pharmaceutical Market Cap
Daihan Pharmaceutical has a market cap or net worth of 170.23 billion as of April 24, 2026. Its market cap has increased by 13.98% in one year.
Market Cap
170.23B
Enterprise Value
80.70B
Revenue
208.61B
Ranking
n/a
PE Ratio
6.16
Stock Price
28,950.00
Market Cap Chart
Since March 1, 2001, Daihan Pharmaceutical's market cap has increased from 22.26B to 170.23B, an increase of 664.72%. That is a compound annual growth rate of 8.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 170.52B | -0.85% |
| Dec 30, 2025 | 171.99B | 11.64% |
| Dec 30, 2024 | 154.06B | -5.59% |
| Dec 28, 2023 | 163.17B | -11.13% |
| Dec 29, 2022 | 183.60B | 6.62% |
| Dec 30, 2021 | 172.20B | -12.90% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samil Pharmaceutical Co.,Ltd | 204.23B |
| REYON Pharmaceutical | 202.85B |
| AptaBio Therapeutics | 202.55B |
| Jeil Pharmaceutical Co.,Ltd | 201.82B |
| JW Lifescience | 198.82B |
| SAMSUNG PHARM. Co., LTD. | 196.71B |
| Whan In Pharm | 195.01B |
| Hana Pharm | 170.09B |